Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
44 Cards in this Set
- Front
- Back
- 3rd side (hint)
Amantidine
|
Blocks viral membrane protein M2 (H+ ion channel); prevents viral endocytosis and uncoating
|
Effective against influenza A only
|
|
Oseltamivir
|
Sialic acid analog that inhibits neuraminidase
|
Effective against both influenza A and influenza B
|
|
Ribavirin
|
Guanosine analog; prevents viral mRNA capping and inhibits RNA-dependent RNA-polymerases
|
Indicated for children with RSV; Hepatitis C, concurrent with IFN-α treatment
|
|
Rimantadine
|
Blocks viral membrane protein M2 (H+ ion channel); prevents viral endocytosis and uncoating
|
Effective against influenza A only
|
|
Zanamivir
|
Sialic acid analog that inhibits neuraminidase
|
Effective against both influenza A and influenza B
|
|
Entecavir
|
Guanosine analog; inhibits HBV DNA polymerase
|
Lamivudine-resistant HBV
|
|
Interferon
|
Induction of host cell enzymes that inhibit viral RNA translation
|
IFNα: Chronic hepatitis B and C, CML, HHV-8; IFNβ: relapsing-remitting MS; IFNγ: chronic granulomatous disease
|
|
Lamivudine
|
Cytosine analog
Inhibits DNA polymerase in HepB and reverse transcriptase in HIV Must be phosphorylated by intracellular enzymes |
Hepatitis B; HIV
|
|
Telbivudine
|
Thymidine analog
Either directly inhibits viral DNA polymerase or is incorporated into growing DNA, terminating elongation |
HBV
|
|
Acyclovir
|
Guanosine analog
Intravenous administration Monophosphorylated inside cell by viral-encoded thymidine kinase Di- and tri-phosphorylation via host cell enzymes Incorporated into viral DNA, leading to chain termination Can also bind directly to thymidine kinase and irreversibly inhibit enzyme |
HSV infections, given prophylactically in immunocompromised or pre-transplant patients; also EBV, VZV
|
|
Cidofovir
|
Cytosine nucleotide analog
|
CMV-induced retinits in AIDS patients
|
|
Famciclovir
|
Acyclic guanosine analog
Similar mechanism as ganciclovir Prodrug that is converted to penciclovir |
PO treatment of herpes zoster
|
|
Fomivirsen
|
Antisense oligonucleotide directed against CMV mRNA
|
Refractory CMV retinitis
|
|
Foscarnet
|
Phosphonoformate (pyrophosphate derivative)
Reversibly inhibits viral RNA and DNA polymerases |
HSV, VZV, CMV that doesn't respond to other treatments
|
|
Ganciclovir
|
Administered IV
Acyclovir analog with relatively specific activity against CMV in a thymidine kinase-independent manner Incorporated into growing DNA strand, inhibiting elongation |
CMV infection, retiniits
|
|
Penciclovir
|
Topical administration
Acyclic guanosine analog with similar mechanism as acyclivor |
Topical treatment of HSV-1, HSV-2, VZV
|
|
Valacyclovir
|
Guanosine analog
Oral administration Monophosphorylated inside cell by viral-encoded thymidine kinase Di- and tri-phosphorylation via host cell enzymes Incorporated into viral DNA, leading to chain termination Can also bind directly to thymidine kinase and irreversibly inhibit enzyme |
HSV infections, given prophylactically in immunocompromised or pre-transplant patients; also EBV, VZV
|
|
Valganciclovir
|
Administered PO
Acyclovir analog with relatively specific activity against CMV in a thymidine kinase-independent manner Incorporated into growing DNA strand, inhibiting elongation |
CMV infection, retiniits
|
|
Vidarabine
|
Adenosine analog, converted to ara-ATP analog, which inhibits viral DNA synthesis
|
Immunocompromised patients with herpetic and vaccinial keratitis & HSV keratoconjunctivitis
|
|
Adefovir
|
Nucleotide analog that is incorporated into viral DNA and subsequent termination
|
|
|
Abacavir
|
NRTI
|
|
|
Didanosine
|
NRTI
|
|
|
Emtricitabine
|
NRTI
|
|
|
Lamivudine
|
NRTI
|
|
|
Stavudine
|
NRTI
|
|
|
Tenofovir
|
NRTI
|
|
|
Zidovudine
|
NRTI
|
|
|
Delavirdine
|
NNRTI
|
|
|
Efavirenz
|
NNRTI
|
|
|
Nevirapine
|
NNRTI
|
|
|
Etravirine
|
NNRTI
|
|
|
Atazanavir
|
HIV Protease Inhibitor
|
|
|
Darunavir
|
HIV Protease Inhibitor
|
|
|
Fosamprenovir
|
HIV Protease Inhibitor
|
|
|
Indinavir
|
HIV Protease Inhibitor
|
|
|
Lopinavir
|
HIV Protease Inhibitor
|
|
|
Nelfinavir
|
HIV Protease Inhibitor
|
|
|
Ritonavir
|
HIV Protease Inhibitor
|
|
|
Saquinavir
|
HIV Protease Inhibitor
|
|
|
Tipranavir
|
HIV Protease Inhibitor
|
|
|
Darunavir
|
Blocks gp41; inhibits viral entry
|
|
|
Enfuvirtide
|
Blocks gp41; inhibits viral entry
|
|
|
Maraviroc
|
Blocks gp41; inhibits viral entry
|
|
|
Raltegravir
|
HIV Integrase inhibitor
|
|